COMPARISON OF BASIC FIBROBLAST GROWTH-FACTOR LEVELS IN CLONE-A HUMAN COLON-CANCER CELLS IN-VITRO WITH LEVELS IN XENOGRAFTED TUMORS

被引：6

作者：

MCCARTY, LP

KARR, SM

HARRIS, BZ

MICHELSON, SG

LEITH, JT

机构：

[1] BROWN UNIV,SCH MED,DEPT RADIAT MED,RADIAT RES LABS,PROVIDENCE,RI 02912

[2] SYNTEX CORP,DEPT BIOMATH,PALO ALTO,CA 94303

来源：

BRITISH JOURNAL OF CANCER | 1995年 / 72卷 / 01期

关键词：

BASIC FIBROBLAST GROWTH FACTOR; XENOGRAFTED TUMORS; HYPOXIA; HOST CELLS;

D O I：

10.1038/bjc.1995.269

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We measured levels of basic fibroblast growth factor (FGF-2) in human colon cancer cells (clone A) in vitro and in xenografted solid tumours using a commercial enzyme-linked immunoassay. In Vitro, levels in unfed plateau phase or exponentially growing cells were low, averaging respectively about 2 and 8 pg 10(-6) cells. However, when solid tumours (average volumes 787 mm(3)) were cut into halves and either enzymatically disaggregated to obtain a cellular fraction or extracted in toto, levels were much higher. In the cellular fraction, values averaged 110 pg 10(-6) cells, while in whole tumour extracts, average values were 24 pg mg(-1) tumour tissue. These results indicate that growth factor levels in solid neoplasms may differ markedly from those predicted from in vitro measurements. We hypothesise that the apparent increase in FGF-2 levels in vivo results primarily from the presence of a significant fraction of host cells (in particular, macrophages, which may contain high levels of FGF-2) within xenografted clone A neoplasms.

引用

页码：10 / 16

页数：7

共 45 条

[31]

Moscatelli D., Presta M., Joseph-Silverstein J., Rifkin D.B., Both normal and tumor cells produce basic fibroblast growth factor, J, Cell. Physiol, 129, pp. 273-276, (1986)

[32]

Motoo Y., Sawabu N., Nakanuma Y., Expression of epidermal growth factor and fibroblast growth factor in human hepatocellular carcinoma: An immunohistochemical study, Liver, 11, pp. 272-277, (1991)

[33]

Murono E.P., Washburn A.L., Goforth D.P., Wu N., Evidence for basic fibroblast growth factor receptors in cultured immature leydig cells, Mol. Cell. Endocrinol, 88, pp. 39-45, (1992)

[34]

Murthy U., Anzano M.A., Greig R.G., Expression of tgf-a/egf and tgf-0 receptors in human colon carcinoma cell lines, Int. J. Cancer, 44, pp. 110-115, (1989)

[35]

Nakajima M., Morikawa K., Fabra A., Bucana C.D., Fidler U., Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells, J, Natl Cancer Inst, 82, pp. 1890-1898, (1990)

[36]

Nguyen M., Watanabe H., Budson A.E., Richie J.P., Folkman J., Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients, J, Nat Cancer Inst, 86, pp. 356-361, (1994)

[37]

Pallavicini M.G., Lalande M.E., Miller R.G., Hill R.P., Cell cycle distribution of chronically hypoxic cells and determination of the clonogenic potential of cells accumulating in g2 & m phases after irradiation of a solid tumor in vivo, Cancer Res, 39, pp. 1891-1897, (1979)

[38]

Pepper M.S., Ferrara N., Orci L., Montesano R., Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro, Biochem. Biophys. Res. Commun, 189, pp. 824-831, (1992)

[39]

Porschen R., Porschen W., Mohlensiepen H., Feinendegen L.E., Cell loss from viable and necrotic tumour regions measured by 125i-udr, Cell Tissue Kinet, 16, pp. 549-556, (1983)

[40]

Rice G.C., Spiro U., Ling C.C., Detection of s-phase overreplication following chronic hypoxia using a monoclonal anti-brdurd, Int. J, Radial. Oncol. Biol. Phys, 11, pp. 1817-1822, (1985)

← 1 2 3 4 5 →